Review paper

Direct oral anticoagulants for unusual‐site venous thromboembolism

Volume: 5, Issue: 2, Pages: 265 - 277
Published: Feb 1, 2021
Abstract
Direct oral anticoagulants (DOACs) are currently the preferred oral anticoagulant treatment for most of the patients with deep vein thrombosis of the lower extremities and/or pulmonary embolism. DOACs have several advantages over vitamin K antagonists, such as availability of fixed dosages, fewer drug interactions, faster onset of action, shorter half-life, and lower risk of major and intracranial bleeding. Although the evidence on the use of...
Paper Details
Title
Direct oral anticoagulants for unusual‐site venous thromboembolism
Published Date
Feb 1, 2021
Volume
5
Issue
2
Pages
265 - 277
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.